NCT00106886View on ClinicalTrials.gov

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

PHASE4UnknownINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

October 31, 2005

Conditions
Cardiovascular DiseaseMyocardial InfarctionStrokeCancer
Interventions
DRUG

Folic acid, vitamin B6 and B12 or placebo

Trial Locations (1)

L8L 2X2

McMaster University and Hamilton Health Sciences Corporation, Hamilton

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Population Health Research Institute

OTHER

lead

Hamilton Health Sciences Corporation

OTHER